Lanean...

Precision medicine: from pharmacogenomics to pharmacoproteomics

Disease progression and drug response may vary significantly from patient to patient. Fortunately, the rapid development of high-throughput ‘omics’ technologies has allowed for the identification of potential biomarkers that may aid in the understanding of the heterogeneities in disease development...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Proteomics
Egile Nagusiak: Chambliss, Allison B., Chan, Daniel W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5037608/
https://ncbi.nlm.nih.gov/pubmed/27708556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-016-9127-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!